Combining Vyvanse and Lamotrigine in MDD, Anxiety, and ADHD
Yes, combining Vyvanse (lisdexamfetamine) with lamotrigine is appropriate and supported for a patient with major depressive disorder, anxiety, and ADHD, with specific considerations for sequencing and monitoring.
Treatment Approach
Primary ADHD Management with Stimulants
Stimulants like Vyvanse should be the first-line treatment for ADHD, even in the presence of comorbid depression and anxiety 1. The AACAP guidelines explicitly state that if MDD is less severe or not primary, there is an advantage to performing a stimulant trial first because onset is rapid and reduction in ADHD-related morbidity can substantially impact depressive symptoms 1.
- For comorbid anxiety: Early concerns about stimulants worsening anxiety have been refuted. The MTA study showed that ADHD patients with comorbid anxiety actually had better treatment responses to stimulants 1
- For comorbid depression: If depression is not severe (no psychosis, suicidality, or severe neurovegetative signs), treat ADHD first and reassess depressive symptoms after ADHD improvement 1
Lamotrigine as Mood Stabilizer Augmentation
Medication combinations for multiple disorders in the same patient (e.g., a stimulant for ADHD and a mood stabilizer for depression) are explicitly recognized as appropriate 2.
Lamotrigine has demonstrated efficacy for:
- Adult ADHD comorbid with mood disorders: A case series of 40 patients showed 77.5% improvement when lamotrigine was combined with ADHD medications, with a mean dose of 125.6 mg 3
- Treatment-resistant depression: Lamotrigine augmentation accelerated antidepressant onset and showed efficacy on core depressive symptoms 4, 5
- Bipolar II depression: Particularly relevant if mood instability is present 3
Safety Profile of the Combination
No Significant Drug Interactions
Lamotrigine can be safely combined with most psychotropic drugs 6. A systematic study of 1,733 serum samples found no interaction between lamotrigine and stimulants. The only significant interactions were with:
- Carbamazepine, phenytoin, phenobarbital (decrease lamotrigine levels)
- Valproate (increases lamotrigine levels)
- Ethinylestradiol (decreases lamotrigine levels)
Serotonin Syndrome Considerations
While Vyvanse carries a warning about serotonin syndrome, this primarily concerns combinations with MAOIs or multiple serotonergic agents 7. Lamotrigine is not serotonergic, so this combination does not increase serotonin syndrome risk. However, if SSRIs are added later for residual anxiety, monitor for serotonin syndrome symptoms during the first 24-48 hours after dosage changes 8.
Monitoring Requirements
From the Vyvanse FDA label 7:
- Blood pressure and heart rate regularly
- Mental status changes: Watch for new/worsening anxiety, agitation, or mood symptoms
- Appetite and weight: Common side effects include decreased appetite
- Sleep disturbances: Insomnia is common (2% discontinuation rate in adults)
Clinical Algorithm
Start Vyvanse for ADHD (typical adult dose 30-70 mg once daily)
- Monitor for 2-4 weeks
- Assess ADHD symptom response and impact on mood/anxiety
If ADHD improves but depression/mood instability persists:
If anxiety remains problematic after ADHD treatment:
Common Pitfalls to Avoid
- Don't delay ADHD treatment due to comorbid anxiety—this is outdated practice 1
- Don't assume all mood symptoms require separate medication—ADHD symptom reduction often improves secondary depression 1
- Don't combine lamotrigine with valproate without dose adjustment (valproate doubles lamotrigine levels) 6
- Don't abruptly discontinue Vyvanse—risk of rebound symptoms and potential physical dependence after prolonged use 7
The combination is well-supported by guidelines for treating multiple comorbid conditions 2, with lamotrigine showing specific promise in ADHD patients with mood disorders 3.